DENTSPLY SIRONA (NASDAQ:XRAY) Cut to “Market Perform” at Leerink Partners

Leerink Partners downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from an outperform rating to a market perform rating in a research report released on Thursday morning, MarketBeat reports.

Other analysts also recently issued reports about the company. Barrington Research restated an “outperform” rating and set a $36.00 price objective on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Stifel Nicolaus cut their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Evercore ISI decreased their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Needham & Company LLC cut their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Finally, Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Six analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $17.86 on Thursday. The stock has a fifty day moving average price of $24.68 and a 200 day moving average price of $25.86. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA has a 52 week low of $17.21 and a 52 week high of $37.60. The firm has a market capitalization of $3.62 billion, a P/E ratio of -8.63, a PEG ratio of 1.31 and a beta of 1.02.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same period in the prior year, the firm posted $0.49 EPS. The company’s revenue was up .4% on a year-over-year basis. Equities research analysts anticipate that DENTSPLY SIRONA will post 1.98 earnings per share for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of large investors have recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. boosted its position in DENTSPLY SIRONA by 8.7% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 40,015 shares of the medical instruments supplier’s stock valued at $1,328,000 after buying an additional 3,219 shares during the last quarter. Nordea Investment Management AB grew its stake in DENTSPLY SIRONA by 6.7% during the 1st quarter. Nordea Investment Management AB now owns 83,898 shares of the medical instruments supplier’s stock valued at $2,784,000 after purchasing an additional 5,288 shares in the last quarter. Daiwa Securities Group Inc. grew its stake in DENTSPLY SIRONA by 7.9% during the 1st quarter. Daiwa Securities Group Inc. now owns 17,652 shares of the medical instruments supplier’s stock valued at $585,000 after purchasing an additional 1,296 shares in the last quarter. Central Pacific Bank Trust Division purchased a new stake in DENTSPLY SIRONA during the 1st quarter worth approximately $64,000. Finally, GSA Capital Partners LLP acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at approximately $655,000. 95.70% of the stock is owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.